Key Insights

Highlights

Success Rate

84% trial completion

Published Results

64 trials with published results (31%)

Research Maturity

136 completed trials (65% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 39/100

Termination Rate

12.5%

26 terminated out of 208 trials

Success Rate

84.0%

-2.6% vs benchmark

Late-Stage Pipeline

33%

68 trials in Phase 3/4

Results Transparency

47%

64 of 136 completed with results

Key Signals

64 with results84% success26 terminated

Data Visualizations

Phase Distribution

158Total
Not Applicable (34)
P 1 (20)
P 2 (36)
P 3 (43)
P 4 (25)

Trial Status

Completed136
Unknown28
Terminated26
Recruiting9
Withdrawn6
Active Not Recruiting2

Trial Success Rate

84.0%

Benchmark: 86.5%

Based on 136 completed trials

Clinical Trials (208)

Showing 20 of 20 trials
NCT06825702Phase 2RecruitingPrimary

Safety, Tolerability and Efficacy of Intravitreal KIO-104 in Patients With Macular Edema

NCT06962839Phase 2RecruitingPrimary

A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema

NCT04129021Not ApplicableRecruiting

High Resolution, High-speed Multimodal Ophthalmic Imaging

NCT04187443Phase 1Recruiting

MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema

NCT06011798Phase 2Completed

Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE)

NCT07090044Phase 4Completed

Comparing Post-intravitreal Injection Pain Scores Using Loteprednol, Bromfenac Sodium, and Artificial Tears Over a 24-hour Period

NCT06305416Phase 3Recruiting

A Efficacy and Safety Study of Ranibizumab 10mg/ml Injection (Incepta) in Patients With Diabetic Macular Edema

NCT04635800Phase 1CompletedPrimary

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of IVT MHU650 in Macular Edema Patients

NCT03751501Not ApplicableCompletedPrimary

Targeted Laser in Diabetic Macular Edema

NCT06511700Enrolling By InvitationPrimary

Implementation of the Intravitreal Injection Administered by Nurses

NCT05698329Phase 1Active Not Recruiting

Effect of AIV007 by Periocular Administration in Subjects with Macular Edema Secondary to Neovascular Age-related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME)

NCT05976139Not ApplicableRecruitingPrimary

Micropulsed Laser in Patients With Macular Oedema in Retinal Dystrophies

NCT01485575RecruitingPrimary

Mechanical Properties of the Internal Limiting Membrane and Intraoperative Utility of Brilliant Blue g (Bbg) and Indocyanine Green (Icg) Assisted Chromovitrectomy

NCT05003258Not ApplicableCompletedPrimary

Functional and Anatomical Outcomes of Dexamethasone Intra-vitreal Implant in Patients with Resistant Macular Edema Secondary to Retinal Vein Occlusion After Intravitreal Anti-VEGF Injection

NCT06176963Phase 2Completed

A Study to Evaluate the Usability of the SB11 PFS in Subjects With Wet AMD or Macular Oedema Secondary to RVO

NCT06686641Active Not RecruitingPrimary

Incidence of Macular Edema in a Uveitis Population

NCT04292912Phase 1TerminatedPrimary

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2798745 in Participants With Diabetic Macular Edema

NCT05158699Phase 3TerminatedPrimary

Effectiveness of Periocular Drug Injection in CATaract Surgery

NCT06595355Phase 2Recruiting

Efficacy and Safety of Intravitreal Injection of Bevacizumab with and Without Oral Curcumin

NCT04740905Phase 3CompletedPrimary

A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion

Scroll to load more

Research Network

Activity Timeline